sildenafil-citrate and beta-Thalassemia

sildenafil-citrate has been researched along with beta-Thalassemia* in 3 studies

Other Studies

3 other study(ies) available for sildenafil-citrate and beta-Thalassemia

Article	Year
COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension. Hemoglobin, 2020, Volume: 44, Issue:3 We here report the successful recovery from coronavirus disease-19 (COVID-19) pneumonia in a patient with β-thalassemia major (β-TM) and severe pulmonary arterial hypertension (PAH), focusing on the patient's comorbidities, therapeutic course and drug interaction. Topics: Angiotensin Receptor Antagonists; beta-Thalassemia; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Drug Interactions; Humans; Pandemics; Phosphodiesterase 5 Inhibitors; Pneumonia, Viral; Pulmonary Arterial Hypertension; SARS-CoV-2; Sildenafil Citrate; Treatment Outcome	2020
Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2012, Volume: 78, Issue:2 We report a case of a 37-years-old man, affected by thalassemia major, hypogonadotropic hypogonadism, chronic HCV-hepatitis, diabetes mellitus, severe osteoporosis, prior septic pulmonary embolism and pulmonary artery hypertension was performed a long-term treatment with high-dose of sildenafil (120 mg/die) with reduction of pulmonary arterial systolic pressure and of the dyspnea. Topics: Adult; beta-Thalassemia; Comorbidity; Hepatitis, Viral, Human; Humans; Hypertension, Pulmonary; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents	2012
Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension. Blood, 2002, Aug-15, Volume: 100, Issue:4 Topics: Adult; beta-Thalassemia; Humans; Hypertension, Pulmonary; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents	2002